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ABSTRACT  We  report  here that interleukins  have  a dramatic  effect  on  extracellular  matrix 
production  by cultured endothelial cells.  Human  umbilical  vein  endothelial cells  incubated 
with  growth  media  conditioned  by  lectin-activated  human  peripheral  blood  mononuclear 
leukocytes undergo marked changes in cell shape and elaborate a highly organized extracel- 
lular  material  that  is  not  detectable  in  untreated  cultures.  This  material  has the  following 
characteristics:  (a) it is not recognizable by electron microscopy unless the cationic dye, Alcian 
blue, is added to the fixative; (b) it is visualized  as a network of branching and anastomosing 
fibrils of various thickness that can be resolved  into bundles of fine filaments; (c) it is associated 
with the cell surface, extends between contiguous cells, and coats the culture substrate; (d) it 
is removed by digestion with glycosaminoglycan-degrading enzymes, such as crude heparinase 
and chondroitinase ABC. These results demonstrate that soluble factors  released by activated 
peripheral  blood  mononuclear leukocytes (interleukins) stimulate cultured human  umbilical 
vein endothelial cells to produce a highly structured pericellular matrix containing glycosami- 
noglycans  (probably chondroitin sulfate  and/or hyaluronic acid)  as a major constituent. We 
speculate that this phenomenon corresponds to an early step of angiogenesis as observed in 
vivo as a consequence of interleukin release. 
Because of its unique and strategic position,  vascular endo- 
thelium participates in a wide range of normal and patholog- 
ical processes, including inflammation and lymphocyte traffic 
through specialized postcapillary venules in lymphoid tissue 
(14, 34). The role played by endothelial cells in these events 
would  be  better  defined  if the  factors that  modulate  their 
physiological properties were identified. 
There is increasing evidence that  lymphoid cell products 
may  profoundly  affect  vascular  endothelium.  Antigen-  or 
mitogen-activated mononuclear leukocytes synthesize and re- 
lease an array of soluble factors (collectively called lympho- 
kines or interleukins) that have a wide spectrum of regulatory 
activities on both lymphoid (38, 44) and nonlymphoid cells 
(33, 44, 54), and several observations suggest that endothelial 
cells can also be a target of interleukin activity (2,  9,  12,  13, 
39,  41,  49).  This  prompted  us  to  investigate  the  effect  of 
interleukins  on endothelial  ceils in an in  vitro system.  For 
this  purpose,  monolayer cultures  of human  umbilical  vein 
endothelial  (HUVE) ~ cells were incubated with cell-free su- 
pernatants from cultures of lectin-activated mononuclear leu- 
kocytes and examined by electron microscopy. The results of 
this study show that interleukins induce cultured HUVE cells 
to elaborate a highly organized pericellular matrix containing 
cytochemically recognized glycosaminoglycans (GAG)  as  a 
major constituent. 
MATERIALS  AND  METHODS 
Cell Culture:  Primary  cultures of HUVE cells were prepared by an 
adaptation of  previously  described  methods  (17, 28). Briefly,  the umbilical  vein 
was perfused with 50 ml of Hanks' balanced salt solution to wash out the 
blood, and filled with Medium 199 (Gibeo Laboratories, Grand Island, NY) 
containing I mg/ml collagenase  (CLS, Type  I, Worthington  Biochemical  Corp., 
Freehold, N  J). A~er  a 20-rain incubation at 37°C, the contents of  the vein  were 
Abbreviations used in this paper: GAG, glycosammoglycans; HUVE 
(cell), human umbilical vein endothelial (cell); PBL, peripheral blood 
mononuclear leukocyte; PHA, phytohemagglutinin. 
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conditions,  this collagenase effluent usually contained  only a limited  number 
of endothelial  cells (I04-10~), the majority  of which did not exclude Trypan 
blue, and was therefore  discarded. The vessel was refilled with Medium  199 
without collagenase and clamped  at its extremities, and the cord was gently 
kneaded between the fingers for ~2 rain to loosen the residual endothelial cells. 
The umbilical vein was then perfused with 40 ml of Medium  199, and the cells 
were collected by centrifugation  at 150 g for 7 min, washed once, and resus- 
pended  in Medium  199  (we are grateful  to Dr.  C.  Ody for suggesting this 
procedure, which routinely yielded 0.5-1.5  x  106 viable cells). The endothelial 
cells were grown in 16-mm Nunclon plastic culture wells (Nunc, Kampstrup, 
Roskilde, Denmark) with Medium 199 containing 20% fetal calf serum (Gibeo 
Laboratories),  400  U/ml penicillin,  200  ~g/ml streptomycin,  and 4  mM L- 
glutamine. The culture medium was renewed at 48-h intervals. 
Primary cultures of pig aortic endothelial cells were kindly provided by Dr. 
A. Junod (Pneumology  Division,  University  Hospital,  Geneva,  Switzerland) 
and cultured  on gelatin-coated  dishes with medium RPMl-1640  containing 
20%  fetal calf serum and 4 mM L-glutamine. Fetal bovine  heart  endothelial 
cells (CRL  1345) were obtained  from the American  Type Culture  Collection 
(Rockville, MD) and grown in Dulbeeco's  modified  Eagle's medium (Gibco 
Laboratories)  supplemented  with  10%  newborn calf serum and  100  ~g/ml 
fibroblast growth factor (Collaborative Research, Waltham,  MA) (19). Cloned 
bovine  capillary  endothelial  cells, a  kind  gift  of Dr.  B.  Zetter  (Children's 
Hospital,  Boston,  MA),  were  cultured  on gelatin-coated  dishes  with  a  1:1 
mixture of Dulbecco's  modified  Eagle's  medium and  sarcoma-conditioned 
medium supplemented  with 10% calf serum as described (15). 
A variety of nonendothelial  cells were also used in this study: HeLa cells 
were obtained from Dr. J. Roth, and normal rat liver cells from Dr. G. Vergani; 
human Chang liver cells (CCL 13), human intestine epithelial cells (Henle 407, 
CCL 6), and baby hamster kidney  fibroblasts (BHK-21, CCL  10) were pur- 
chased from the American Type Culture Collection. These cells were grown in 
Medium FI 1 (Gibeo Laboratories) supplemented with 10% fetal calf serum. 
Preparation of Activated  Peripheral Blood  Mononuclear 
Leukocyte Supernatants:  Peripheral  blood mononuclear  lcukocytes 
(PBL) were isolated from heparinized  blood of healthy human volunteers by 
centrifugation  on a Ficoll-Hypaque gradient, according to a modification (25) 
of the method of B6yum (5). The cells were suspended in medium RPMI-1640 
and  incubated  at  37°C in  100-mm  plastic  culture  dishes  (Falcon  Plastics, 
Oxnard, CA). After 60 min, nonadherent cells were recovered and cultured at 
a concentration  of 2 x  106 cells/ml in medium RPMI-1640 supplemented with 
3.4 mM L-glutamine and 5% decomplemented  human serum, with or without 
2 #g/ml phytohemagglutinin  (PHA) (Wellcome, Beckenham, England) for 48 
h at 37°C. At the end of the incubation  period, the cells were sedimented by 
centrifugation and the culture supernatants (which are referred to as activated 
PBL supematants) were filtered through 0.22-/~m Millipore filters (Millipore 
Corp., Medford, MA) and stored at -20"C until use. The biological activity of 
the supernatants was tested for intedeukin  2 as described (20) using an inter- 
leukin  2-dependent  mouse cell line. All  supernatants had high IL2 activity. 
Controls consisted of either medium RPMI-1640 containing 2 ug/ml PHA, or 
supernatants from unstimulated  cultures to which PHA was added immediately 
before collection. For some experiments, the supernatant was concentrated  10- 
fold by ultrafiltration  through an Amicon PM-10 membrane (Amicon Corp., 
Danvers, MA) with a molecular weight eutoffof 10,000, and the retentate was 
diluted  to the  original  volume by the addition  of medium without serum. 
Supernatants  from pig blood and bovine spleen leukocytes were prepared in a 
similar way. 
Incubation  of  Cells  with  Activated  PBL  5upematants: 
Endothelial  and nonendothelial  cells plated  on  16-mm  plastic  culture  wells 
were grown to confluency (usually 3-5 d in the case of  HUVE cells) in standard 
medium before  starting  the experiments.  Supernatants  from activated  PBL 
were then added to the culture media to obtain a final concentration  of 300 #l/ 
ml, and renewed at 48-h intervals. Control cultures were exposed to the same 
dilution  of RPMI-1640  medium containing  2 ug,/ml PHA or, in some experi- 
ments, to the supernataut of unstimulated  PBL. After 4-6 d of incubation,  the 
cells were fixed by replacing the culture medium with either 2.5% glutaralde- 
hyde in 0. l M cacodylate buffer, pH 7.4, or the same fixative containing 0.5% 
Alcian blue 8GX (Lot 13794, Gun" Ltd., London, England) (4). 
Treatment  of Endothelial  Cells  with  GAG-degrading  En- 
zymes:  To investigate the nature of the material staining with Alcian blue, 
live endothelial cell cultures (previously exposed to activated PBL supernatants 
as described  above) were incubated  with each  of the following enzymes: (a) 
crude heparinase  from Flavobacterium heparinum, which degrades all known 
GAG except  keratan  sulfate  (16, 29,  30); (b)  chondroitinase  ABC, which 
degrades  chondroitin-4-sulfate,  cbondruitin-6-sulfate,  dermatan  sulfate,  and 
hyaluronic  acid,  but not heparin  and  heparan  sulfate (10, 56,  57); and (c) 
human platelet heparitinase,  which is specific for heparan sulfate and heparin 
(35, 37, 55). Crude hcparinase (a generous gift of Dr. Alfred Linker, Veterans 
Administration  Hospital, Salt Lake City, UT) was dissolved in either phosphate- 
buffered saline (PBS) or serum,free Medium 199 (pH 7.0) at a concentration 
of  0.5-1  mg/ml. The endothelial cells were incubated with the enzyme for 1-3 
h  at  33°C. Chondroitinase  ABC (Miles Laboratories  Inc.,  Elkhart,  IN) was 
dissolved in Hanks' balanced salt solution (pH 7.4) at a concentration  of 2 U/ 
ml (53). The cells were incubated  for 3 h at 37"(2. Partially purified human 
platelet heparitinase (35, 55) (a generous gift of Dr. Ake Wasteson, Biomedical 
Center, Uppsala, Sweden) was dialyzed against PBS (pH 6.5) and used without 
further dilution. Incubations were done for 1-3 h at 37°C. 
Control  cultures  were  incubated  under the  same conditions  of pH  and 
temperature  as experimental  cultures, but in enzyme-free buffer solutions. At 
the end  of the  incubation  period,  the cells were  rinsed  in buffer,  fixed in 
glutaraldehyde-Alcian blue as described above, and further processed for elec- 
tron microscopy. 
The possible presence of proteolytic  activity  in the crude  heparinase  and 
chondroitinase ABC was assayed by adding 100 jzl of  enzyme solution to 50 ~1 
of a  2%  (wt/vol)  suspension  of casein  (Carnation  Instant non-fat  dry milk 
heated  for 20 min in a boiling water bath and spun at 300 g for 10 min to 
remove aggregates), and measuring the decrease in absorbance at 410 nm with 
a  Dynatech  AM  120  Microelisa-auto-reader  spectrophotometer  (Dynatech 
Corp.,  Alexandria,  VA). Casein  lyric activity  was compared  with  that  of 
dilutions  (0.01-10/~g/ml)  of trypsin (Trypsin  1:250, Difco Laboratories,  De- 
troit, MI). 
Processing  for Electron  Microscopy:  After primary fixation  in 
glutaraldehyde  or giutaraldchyde-Alcian  blue  (see above),  the cultures  were 
rinsed in 0.1  M eacodylate buffer and postfixed for 20  min in  1%  osmium 
tetroxide in Veronal acetate buffer. They were then treated quickly (~ 1 min) 
with 0.1% tannic acid (Mallinckrodt Inc., St. Louis, MO) in 50 mM cacodylate 
buffer, pH 7.0, washed, stained en bloc with 0.5% uranyl acetate in Veronal 
acetate buffer for 20 rain,  dehydrated  in graded ethanols,  and embedded  in 
EPOn. 
Sectioning:  After  polymerization,  the  Epon disks  covering  the  cell 
monolayers, together with the plastic base of the culture  wells, were cut into 
small "matchsticks" with a cross-sectional area of ~ 1 mm  2, using a fine circular 
saw. The small square  of culture  well plastic that remained  attached  to the 
Epon matchstick was removed with forceps, thus leaving the embedded mon- 
olayer directly exposed for sectioning. To achieve an adequate visualization of 
the alcianophilic material coating the culture substrate, care was taken to collect 
the very first sections  obtained  from each  Epon matchstick,  the sectioning 
plane being almost parallel to the base of the exposed monolayer. In this way, 
at least one edge of each section grazed the substrate-attached  material, provid- 
ing useful en face views of its organization.  To cut sections perpendicular  to 
the plane of the culture, the matehsticks were reembedded  in flat moulds to 
obtain the desired orientation.  Thin sections were stained with uranyl acetate 
and lead citrate and examined in a Philips EM 300 (Philips Electronic Instru- 
ments, Inc., Mahwah, NJ) or a Zeiss EM  10 electron microscope (Carl Zeiss, 
Inc., New York). 
Immunofluorescence  Microscopy:  Cells grown  on  glass cover- 
slips were fixed in 3.5% formaldehyde in PBS for 10 min, and permeabilized 
with 0.5% Triton X-100 in PBS for 10 min. They were then incubated for 2 h 
at room temperature  in a moist chamber with rabbit antihuman Factor VIII 
antiserum (Nordic  Immunology, Tilburg,  The Netherlands)  at  1:20 dilution, 
washed in PBS, and further  incubated  for 1 h with a  1:100 dilution  of sheep 
anti-rabbit  IgG  antiserum  labeled with  fluorescein  isothiocyanate  (Institut 
Pasteur,  Paris, France).  For the visualization of fibronectin  matrices, control 
and heparinase-treated  cultures were incubated  with a  1:20 dilution  of rabbit 
anti-mouse  fibronectin  antiserum (a kind  gift of Dr.  B.  Dumont, Dept.  of 
Pathology, University of  Geneva) followed by washing and indirect staining for 
rabbit IgG as described above. After additional  washing in PBS, the coverslips 
were mounted on microscope slides with giycerol/PBS and photographs were 
taken with a Zeiss photomicroscope  equipped with epifluorescence optics. 
RESULTS 
General Observations 
The endothelial  nature  of the  cells  recovered from  the 
umbilical vein was ascertained by the following criteria"  (a) 
presence of  Factor VIII antigen in all the cells as demonstrated 
by indirect immunofluorescence (26); (b) presence of Weibel- 
Palade bodies (17,  28)  in  thin  sections; (c)  occurrence of 
endothelial-type tight junctions (50) in freeze-fracture  replicas 
(results not shown); and (d) typical "cobblestone" appearance 
of confluent cultures (17, 28) (cf. Fig.  1  a). Contamination by 
MONTES^NO  ET ^1..  Interleukin-induced  Periendothelial  Cell Matrix  1707 FIGURE  1  Morphological changes  induced by activated PBL supernatants  in confluent cultures of HUVE cells (phase contrast). 
(a) Endothelial cells grown for 4 d  in the presence  of 2/,g/ml  PHA have a characteristic epithelioid "cobblestone" appearance. 
(b) Endothelial cells incubated for 4 d with supernatants  from PHA-activated PBL display an elongated fibroblastoid morphology. 
x  70. 
smooth muscle cells or fibroblasts was never observed. 
Addition to the culture medium ofsupernatants from PHA- 
activated  PBL  resulted  in  marked  morphological changes. 
Whereas confluent endothelial cells grown in the presence of 
either PHA (2 ~g/ml) or supernatants from unstimulated PBL 
maintained a characteristic polygonal, epithelial morphology 
(Fig.  1  a),  cells incubated  with  activated  PBL supernatants 
assumed, within 2-5 d, a spindle-shaped, fibroblastic appear- 
ance (Fig.  1  b). This effect was reversible upon interruption of 
the  treatment  and  was much  more evident in  low density 
cultures, where the cells took on an extremely elongated and/ 
or dendritic morphology. A detailed account of these changes 
and  of the  accompanying reorganization of the  endothelial 
cell cytoskeleton will be given in a separate communication. 
Except for these modifications, major ultrastructural differ- 
ences  between  control  and  interleukin-treated  endothelial 
cells were not noticed in thin sections of glutaraldehyde-fixed 
cultures.  However,  a  striking  difference  between  the  two 
experimental conditions was observed when the cationic dye 
Alcian blue was added to the fixative solution. This difference 
consisted of the presence, in  interleukin-treated endothelial 
cells, of a highly organized alcianophilic pericellular material. 
This material,  which  is described  below,  was  found  in  16 
different HUVE cell cultures, and using five distinct prepa- 
rations  of activated  PBL  supernatants.  In  contrast,  it  was 
never  observed  in  cultures  exposed  to  PHA  alone,  or  to 
supernatants of unstimulated PBL. 
Alcianophilic Pericellular Material 
When Alcian blue was included in the fixative (4), sections 
parallel to the culture plane revealed a cell coat consisting of 
a fine feltwork of moderately electron-dense material (Fig. 2). 
The cell coat of interleukin-treated (but not of control) en- 
dothelial cells contained an additional component appearing 
as highly electron-dense rodlike structures (Fig. 2 b). However, 
sections tangential to the cell surface showed that the Alcian 
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blue-stained  material  was  in  fact  organized  as  a  complex 
network of branching and anastomosing fibrils (Fig.  3).  In 
addition  to  forming a  cage around the  cell periphery (Fig. 
3 a), the fibrillar network extended from the cell surface into 
the extracellular space and joined contiguous endothelial cells 
(Fig. 3 b). In suitable sections, the Alcian blue-stained material 
appeared to  form  a  highly  structured  extracellular  matrix 
composed of interconnecting fibrils of various thickness (Fig. 
4a).  At  high  magnification,  the  coarser and  medium-sized 
fibrils were seen to consist of bundles of fine filaments (per- 
haps corresponding to the thinnest 8-12-nm threads stretched 
between the fibrils) (Fig. 4 b). A further characteristic localiza- 
tion of the alcianophilic material was on the culture substrate 
(Fig.  5).  Sections  grazing  the  substrate  (see  Materials  and 
Methods) usually offered the best and easiest visualization of 
the alcianophilic material, probably because they were nearly 
parallel to the plane of the matrix over a  large area (a rare 
situation in sections cut at different levels, even when passing 
tangential to the cell surface). 
In sections perpendicular to the culture plane, the  upper 
surface of both control and interleukin-treated endothelial cell 
monolayers was covered with a thick feltwork of moderately 
electron-dense material. In interleukin-treated cells, this ma- 
terial contained,  in  addition,  irregularly-spaced globular or 
rod-shaped dense  structures  (Fig.  6),  most probably repre- 
senting transverse or oblique sections of the fibrils described 
earlier. Similar structures also bridged the gap between con- 
tiguous cells (Fig. 6 a) and were deposited on cell-free areas of 
the culture substrate (Fig. 6, c and d). Perpendicular sections 
thus showed the continuity between the material associated 
with  the  endothelial  cell  surface  and  that  present  in  the 
extracellular space or coating the culture substrate (Fig. 6). 
Alcianophilic  material with  a  slightly altered appearance 
could still  be seen 7  d  after interruption of the  interleukin 
treatment (not shown). 
When Alcian blue was omitted from the fixative, no struc- 
tures were seen which corresponded to those described above, FIGURE 2  Thin sections  slightly oblique to the surface  of HUVE  cells fixed in glutaraldehyde-Alcian blue. (a) Endothelial cell 
exposed for 6 d  to  PHA alone (control). The plasma membrane  is covered with a fine feltwork of moderately electron-dense 
material.  (b) Endothelial cell exposed for 6 d to supernatants  from PHA-activated PBL. In addition to the feltlike material,  the cell 
surface presents highly electron-dense rodlike structures  (arrows). (a) x  56,000.  (b) x  55,000. 
and the surface of both control and interleukin-treated cells 
had a similar appearance. In these preparations, fibrillar ma- 
terial  morphologically  indistinguishable  from  fibronectin 
matrices (8,  51) was frequently observed in the extracellular 
space and/or  associated with the  cell surface.  However, its 
organization  and  topographical  distribution  was  different 
from that of the Alcian blue-stainable network. 
To establish whether  the  elaboration  of an  Alcian  blue- 
stainable pericellular matrix was a  phenomenon specific to 
HUVE cells or common to other cell types exposed to the 
same culture conditions, we also incubated the following cells 
with human PBL supernatants and fixed in glutaraldehyde- 
Alcian blue: endothelial cells from pig aorta (primary culture), 
fetal bovine heart (passages 12-17), and bovine adrenal cap- 
illaries; human intestine epithelial cells (Henle 407) and HeLa 
cells; rat liver cells and BHK-21 hamster fibroblasts. In addi- 
tion, because some interleukin activities have a narrow species 
specificity, pig aortic endothelial  cells were also exposed to 
pig leukocyte supernatants, and bovine capillary endothelial 
cells were exposed to bovine leukocyte supernatants.  In no 
instance did we observe a pericellular matrix similar to that 
seen  with  HUVE  cells treated  with  activated  human  PBL 
supernatants. 
Enzyme Digestion Studies 
The chemical composition of the alcianophilic matrix sur- 
rounding interleukin-treated endothelial cells was studied by 
incubating intact cultures with various degradative enzymes 
prior to Alcian blue staining.  In selecting test enzymes, we 
were guided by the known affinity of Alcian blue for GAG 
and by its ability to preserve and visualize extracellular matrix 
proteoglycans in preparative procedures for electron micros- 
copy (4,  52).  Alcianophilic pericellular material was not de- 
monstrable after incubation of the cultures with crude Fla- 
vobacterium heparinum heparinase,  a  GAG-degrading  en- 
zyme preparation of relatively broad specificity (16,  29,  30), 
or with chondroitinase  ABC,  which  acts on  chondroitin-4- 
sulfate, chondroitin-6-sulfate, dermatan sulfate, and hyaluro- 
nic acid (but not on heparin and heparan sulfate) (10, 56, 57). 
MONTESANO  ET  AL.  Interleukin-inducedPeriendothelial  Cell Matrix  1709 FIGURE  3  Interleukin-treated endothelial cells.  In sections tangential to the cell surface,  the electron-dense material appears 
organized as a network of anastomosing fibrils that form a cage around the cell periphery (a), and extend between contiguous 
cells (b). Glutaraldehyde-Alcian blue fixation. (a) x  7,500. (b) x  18,500. 
In contrast, the alcianophilic material resisted digestion with 
partially purified human  platelet heparitinase, which selec- 
tively attacks heparin and heparan sulfate (35,  37,  55) (Fig. 
7). These results are summarized in Table I. Incubation with 
enzyme-free buffer solutions under the same conditions of 
pH and temperature as experimental cultures did not affect 
1710  THE  IOURN^L OF  CELL BIOLOGY • VOLUME 99, 1984 FIGUre 4  Thin section parallel to the plane of the culture. (a) Alcianophilic material forming a highly organized  fibrillar matrix in 
the extracellular space. The matrix consists of interconnecting fibrils of various thickness; (b) higher magnification showing the 
filamentous substructure  of the electron-dense fibrils, and the thinnest 8-12 nm threads (arrows) extending between them. (a) x 
14,000. {b) x  70,000. 
tVlONT[S^NO ET ^L.  Interleukin-induced Periendothelial  Cell Matrix  ] 7 ~ FIGURE 5  Thin section grazing the culture substrate (see Materials and Methods). The alcianophilic material  associated with the 
surface of endothelial cell processes (EC) appears  in continuity with that present  in the extracellular space (lower right of the 
micrograph)  and that laid down on the culture substrate (grayish upper and left part of the micrograph),  x  11,000. 
the  alcianophilic  material.  2 In addition,  the  possibility that 
this  material  was removed by proteases contaminating the 
GAG-degrading  enzymes  was  ruled  out  by  the  following 
controls:  (a) proteolytic activity was undetectable  in  either 
heparinase or chondroitinase ABC by a  spectrophotometric 
casein lysis assay under conditions capable of revealing 0.1 
vg/ml of trypsin (see Materials and Methods); (b) incubation 
of the cultures with 1 t,g/ml trypsin, a concentration 10 times 
higher than the detection threshold of the assay cited above, 
did not affect the alcianophilic network (high concentrations 
of proteolytic  enzymes  could  not  be  tested,  because  they 
caused complete cell detachment); (c) in experiments similar 
to those of Gill et al.  (16),  crude heparinase released more 
than 2.5 times as much of 35S-labeled material from endothe- 
lial  monolayers as that released by the PBS control; in con- 
trast,  release  of [3H]leucine-labeled  material  by heparinase 
2  The presence of an alcianophilic matrix in these cultures (which 
were incubated for 1-3 h in buffer and further washed before fixation) 
precludes the possibility that it represents material precipitated from 
the culture medium during fixation. 
was not significantly different from release by incubation with 
PBS  alone  (Table  II); (d)  the  fibronectin matrix,  which  is 
extremely sensitive to most proteinases, was not affected by 
heparinase digestion: as seen by immunofluorescence micros- 
copy (see Materials and Methods), heparinase-treated cultures 
contained a  dense network of fibronectin, indistinguishable 
from the control (cf. also reference 24). 
DISCUSSION 
Since the recent development of techniques for maintaining 
vascular endothelial cells in vitro, there has been a continuous 
interest in establishing what extracellular matrix components 
are synthesized by these cells and which factors regulate their 
production (for a review, see reference 31). It has been dem- 
onstrated that cultured endothelial cells produce a variety of 
extracellular  components,  including  several  collagen  types 
(46), elastin (32), fibronectin (27), laminin (18), and GAG (6, 
36).  In  this  study,  we  have  shown  that  supernatants  from 
cultures of PHA-activated PBL induce HUVE cells to produce 
a  highly structured extracellular material which can be pre- 
served and/or visualized by including the cationic dye, Alcian 
1712  THE JOURNAL OF CELL BIOLOGY • VOLUME 99, 1984 FIGURE  6  Thin  sections perpendicular to the culture  plane. A  thick feltlike material containing globular or rod-shaped dense 
structures (arrows) covers the upper surface of endothelial cells (a-d) and extends as a bridge between contiguous cells (a and b) 
or cells and culture substrate (c and d). In b, a delicate network of granular and fibrillar densities also fills the intercellular space. 
The ventral cell surface (a and c), the dorsal surface of cells undergrowing other endothelial cells (a and b), as well as the regions 
of the substrate located beneath the cells (a-c) are mostly devoid of associated dense material. Gaps between endothelial cells, 
such as those seen in these micrographs, are especially frequent in interleukin-treated cultures. (a) x  34,000. (b) x  18,500. (c) x 
10,500. (d) x  25,000. 
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Susceptibility of the Alcianophilic  Matrix to Digestion with 
GAG-degrading Enzymes 
Enzymes  Substrate specificity 
Effect on AI- 
cianophilic 
matrix 
Crude heparinase  All  known  glycos-  Removed 
aminoglycans  ex- 
cept keratan sulfate 




Heparitinase  Heparan sulfate  Not affected 
Heparin 
FIGURE  7  Interleukin-treated  endothelial cell  culture  incubated 
with  human platelet heparitinase before AIcian  blue staining. The 
network of  electron-dense  material coating the  culture  substrate 
(cf.  Fig.  5)  has  not  been  removed  by  the  enzyme  treatment,  x 
4,500. 
blue, in the fixative solution. 
The alcianophilic material  is  organized as a  network  of 
branching  and  anastomosing  fibrils  of  various  thickness 
which, at an appropriate magnification, can be resolved into 
bundles of fine filaments.  Individual  8-12-nm  threads  are 
also seen to interconnect the coarse fibrils. Although clearly 
associated with the endothelial cell surface, this material also 
extends between contiguous cells throughout the extracellular 
space,  and is deposited onto the culture substrate forming, 
therefore, an extensive pericellular matrix. 
Enzyme digestion studies were necessary to ascertain the 
chemical nature of this alcianophilic material, in that at the 
pH used during fixation for electron microscopy, Alcian blue 
staining is not specific for GAG as protein carboxyl groups 
and other negative charges may participate in dye binding (4). 
Sensitivity to  crude  heparinase,  a  GAG-degrading enzyme 
preparation  of broad  specificity (16,  29,  30),  resistance to 
human platelet heparitinase (specific for heparin and heparan 
sulfate;  see  references 35,  37,  and  55),  and  sensitivity  to 
chondroitinase ABC (10,  56,  57)  indicate that the alciano- 
philic material contains chondroitin sulfate and/or hyaluronic 
acid.  Although  crude  heparinase  and  chondroitinase ABC 
have  been  reported  previously  not  to  contain  proteolytic 
activity (16),  controls were done which verified that the re- 
moval of the alcianophilic matrix was not caused by contam- 
inating proteases (see Results). 
Interaction with cationic dyes and subsequent tissue proc- 
essing probably alter the native conformation of  GAG causing 
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collapse of the once extended macromolecules (21). Although 
proteoglycans usually appear in the electron microscope as 
dense "granules" (22,  23), in some instances they have been 
seen as elongated rod-shaped particles or branching fibrils (7, 
42,  43,  45,  47,  48),  which  are thought to  result  from less 
extensive condensation of the native macromolecules and to 
more closely reflect the original organization of  the proteogly- 
can  matrix  (7,  42,  43,  45).  Thus,  the  pericellular fibrillar 
network observed in endothelial cultures stimulated by inter- 
leukin-rich supernatants probably represents GAG that have 
been only partially collapsed during fixation. 
Cultured endothelial cells have also been shown to synthe- 
size GAG (6,  36) in the absence of interleukin stimulation. 
However, in  the  present  study,  pericellular networks were 
observed only in endothelial cell cultures previously exposed 
to  interleukin-containing supernatants  and  not  in  control 
cultures. The most likely explanation is that, in our culture 
conditions, interleukins strongly enhance GAG secretion. Sol- 
uble products from lectin-activated PBL have been shown to 
stimulate GAG synthesis by cultured synovial fibroblastic cells 
(1) and, more recently, to enhance the formation of hyaluron- 
ic acid-rich cell coats (as visualized in light microscopy by red 
blood cell exclusion) by cultured glioma cells (11). Although 
it is possible  that interleukins play a role in the modulation 
of GAG secretion by different cell types, among the different 
cells examined in our study, only HUVE cells appeared to 
produce  alcianophilic  pericellular  matrices  in  response  to 
incubation with activated PBL cell supernatants.  However, 
caution should be exercised in interpreting the lack of reactiv- 
ity of endothelial cells from pig aorta, as well as of the fetal 
bovine heart and bovine capillary endothelial cell lines,  be- 
cause this may result from the absence of the active factor in 
pig and bovine supernatants or, in the case of the bovine cell 
lines, from the loss of differentiated properties due to repeated 
subculture. 
An interesting phenomenon accompanying the elaboration 
of alcianophilic matrix in intedeukin-treated endothelial cul- 
tures is the change of cell shape.  The relationship between 
these two consistently associated effects of PBL supernatants 
is presently unclear, but normal endothelial cells plated on 
the  extracellular  matrix  produced  by  other,  intedeukin- 
treated,  endothelial cells  (following removal of the  treated 
cells with Triton X-100) maintain the usual polygonal mor- 
phology (unpublished results). Thus, there is no evidence that 
shape changes result from an altered matrix environment. 
The effect of interleukin-containing supernatants  on  the 
elaboration  of GAG-rich  extracellular  matrix  by  cultured 
HUVE cells raises the question of the functional significance 
of this phenomenon and its possible relevance to biological 
processes occurring  in  vivo.  Soluble  products  released  by 
either lymphocytes (2) or macrophages (40) have been shown 
TABLE  II 
Release of Radioactively Labelled Substrates by Treatment of 
Endothelial Cell Monolayers with Crude Heparinase 
3sS  [3H]Leucine 
cpm 
Crude heparinase  1702  11,964 
PBS  639  11,483 
Interleukin-treated  endothelial  cell cultures were incubated  for 48  h with 
either  80 #Ci/ml 35S or  100 /~Ci/ml [3H]leucine,  extensively washed, and 
treated with crude heparinase or PBS as described in the text. Radioactivity 
released in the supernatant was measured in a liquid-scintillation-counting 
system,  with Aquassur (New England Nuclear, Boston, MA) as the scintillation 
cocktail. to induce the formation of new blood vessels (angiogenesis) 
in various test systems. Angiogenesis is a poorly understood 
phenomenon, and has not been studied ultrastructurally with 
methods  allowing  the  detection  of proteoglycans  until  the 
recent work of Ausprunk et al.  (3) on tumor-induced angi- 
ogenesis  in  rabbit  cornea.  The  salient  finding  of the  latter 
study was the demonstration that the growing tips of capillary 
sprouts are surrounded by a network of proteoglycan granules 
differing in arrangement and composition from those associ- 
ated with  mature microvessels.  Stimulation  of proteoglycan 
synthesis by endothelial cells may thus be one of the first steps 
in the formation of new blood vessels. An attractive hypoth- 
esis, presently under investigation, is that the endothelial cell 
changes we have observed after interleukin stimulation (i.e., 
the  elaboration  of a  highly  organized  proteoglycan  matrix) 
represent the in vitro equivalent of one of the first stages of 
angiogenesis. 
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Note Added in Proof."  In recent experiments, we tested the effect of 
highly purified or recombinant  interleukins on HUVE cell cultures. 
While  recombinant  interleukin  2  had  no  effect,  an  alcianophilic 
pericellular matrix was induced by combined treatment with recom- 
binant  "v-interferon and interleukin  1 (which  also  reproduced the 
shape changes elicited by PBL supernatants) and, occasionally, with 
"v-interferon alone. However, it could not be induced by interleukin 
1 alone.  This suggests a synergistic action of "v-interferon and inter- 
leukin  1 on endothelial cells. 
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